Oncogenes in immune cells as potential therapeutic targets

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Decades of research focused on oncogenes and tumor-suppressor genes in tumor development.
• Proto-oncogene defects are primarily studied in tumor cells, overlooking their presence in immune cells.
• The role of oncogenes in immune cell dysfunction during cancer remains under-assessed.

Purpose of the Study:

• To investigate the under-explored role of oncogene expression in immune cell defects.
• To re-evaluate existing studies on immune-mediated diseases in the context of oncogene signaling.
• To establish a foundation for understanding oncogene impact on cancer-related immune dysfunction.

Main Methods:

• Review of key studies linking immune-mediated diseases with oncogene signaling pathways.
• Focus on research examining proto-oncogene expression in various cell types, including immune cells.
• Synthesis of findings to connect oncogene activity with immune system function in cancer.

Main Results:

• Oncogenes are expressed in immune cells and can influence their function.
• Aberrant oncogene signaling is implicated in immune cell defects relevant to cancer.
• Existing research on immune diseases provides a basis for understanding oncogene-immune interactions.

Conclusions:

• Oncogenes play a significant, yet underappreciated, role in immune system dysfunction during carcinogenesis and tumor progression.
• Further research is needed to fully elucidate the mechanisms by which oncogenes affect cancer immunity.
• This review highlights the importance of considering oncogene signaling in the context of cancer immunology.